The Role of Glutamatergic Neurotransmission in Pathophysiology of Schizophrenia
Authors:
J. Hons
Authors‘ workplace:
Psychiatrická klinika LF UK a FN Hradec Králové, přednosta prof. MUDr. J. Libiger, CSc.
Published in:
Čes. a slov. Psychiat., , 2004, No. 4, pp. 220-228.
Category:
Overview
The dysfunction of the neurons containing excitatory amino acids is present in a wide range ofneurodegenerative disorders. Schizophrenia may also result from a dysfunction of excitatoryamino acid neurotransmission. There are two glutamatergic hypotheses of schizophrenia.Glutamate hypofunction hypothesis supposes hypofunction of cerebral glutamatergic neuronsin schizophrenia. The most signifi cant consequence of the hypothesis is a possible use of drugsenhancing glutamatergic neurotransmission in the treatment of schizophrenic symptoms.Glutamate hyperfunction hypothesis was also proposed. It suggests a possible effect of glutamaterelease-inhibiting drugs in schizophrenia.
Key words:
glutamate, schizophrenia, glutamatergic hypothesis, NMDA receptor.
Labels
Addictology Paediatric psychiatry PsychiatryArticle was published in
Czech and Slovak Psychiatry
2004 Issue 4
Most read in this issue
- Frontotemporal Dementia
- The Role of Glutamatergic Neurotransmission in Pathophysiology of Schizophrenia
- Quetiapine as Treatment of Severe Depressive Disorder
- Moclobemide in the Therapy of ErectionDysfunctions